Why the study?
Do COX-2 selective inhibitors increase the risk of major adverse cardiovascular events?
Do COX-2 selective inhibitors increase the risk of major adverse cardiovascular events?
This paper highlights that COX-2 selective inhibitors may increase cardiovascular risk through multiple potential mechanisms.
Answers are grounded in this paper and cite their sources.
Supports CV risk assessment before COX-2 inhibitor use; leaves open precise mechanisms and risk magnitude.
It appears that in COX-2 selective inhibitors may increase the risk of major adverse cardiovascular events. Various potential mechanisms are presented whereby COX-2 selective inhibitors may enhance the risk of cardiovascular events in certain patients. It is conceivable that different mechanisms may be involved in different circumstances and that multifactorial mechanisms may occasionally be operating in conjunction with one another.
No takes yet. Share an insight, caveat, or question.
Howard S. Smith (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: